Volitionrx (VNRX) Income towards Parent Company (2019 - 2025)
Historic Income towards Parent Company for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$31433.0.
- Volitionrx's Income towards Parent Company rose 3319.09% to -$31433.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 3381.91%. This contributed to the annual value of -$27.0 million for FY2024, which is 2473.74% up from last year.
- Per Volitionrx's latest filing, its Income towards Parent Company stood at -$31433.0 for Q3 2025, which was up 3319.09% from $29992.0 recorded in Q2 2025.
- In the past 5 years, Volitionrx's Income towards Parent Company registered a high of $94092.0 during Q4 2022, and its lowest value of -$9.5 million during Q2 2023.
- Over the past 5 years, Volitionrx's median Income towards Parent Company value was $9424.0 (recorded in 2021), while the average stood at -$2.9 million.
- In the last 5 years, Volitionrx's Income towards Parent Company surged by 79109.72% in 2022 and then tumbled by 1258513.82% in 2023.
- Quarter analysis of 5 years shows Volitionrx's Income towards Parent Company stood at $73088.0 in 2021, then increased by 28.74% to $94092.0 in 2022, then tumbled by 9380.53% to -$8.7 million in 2023, then soared by 33.8% to -$5.8 million in 2024, then surged by 99.46% to -$31433.0 in 2025.
- Its Income towards Parent Company was -$31433.0 in Q3 2025, compared to $29992.0 in Q2 2025 and -$5.5 million in Q1 2025.